Skip to main content

Peer Review reports

From: Clinical response and pharmacokinetics of bendamustine as a component of salvage R-B(O)AD therapy for the treatment of primary central nervous system lymphoma (PCNSL)

Original Submission
17 Jan 2018 Submitted Original manuscript
31 May 2018 Author responded Author comments - Therasa Kim
19 Feb 2018 Reviewed Reviewer Report - Sara Cresta
22 Apr 2018 Reviewed Reviewer Report - Tetsuhiko Asao
30 Apr 2018 Reviewed Reviewer Report - Subramanyeswara Arekapudi
Resubmission - Version 2
31 May 2018 Submitted Manuscript version 2
21 Jun 2018 Author responded Author comments - Therasa Kim
2 Jun 2018 Reviewed Reviewer Report - Tetsuhiko Asao
18 Jun 2018 Reviewed Reviewer Report - Subramanyeswara Arekapudi
Resubmission - Version 3
21 Jun 2018 Submitted Manuscript version 3
Publishing
25 Jun 2018 Editorially accepted
9 Jul 2018 Article published 10.1186/s12885-018-4632-y

You can find further information about peer review here.

Back to article page